GI & Endoscopy

Here are the most-read gastroenterology and endoscopy articles during the week of Feb. 8-12:

Providers have attempted to improve colorectal cancer screening rates by using risk stratification, but recent research debunked the effectiveness of the strategy, according to a study published in February issue of The American Journal of Gastroenterology.

Pinnacle GI Partners has deepened its roots in Michigan, partnering with East Lansing, Mich.-based Digestive Health Institute, PE Hub reported Jan. 10.

Barry Kaufman, MD, of Egg Harbor Township, N.J.-based Atlantic Gastroenterology Associates, developed a COVID-19 testing program that has allowed his ASC to remain open and perform high procedure volumes through the COVID-19 pandemic.

Here are four updates from GI companies and practices over the past week:

Chattanooga, Tenn.-based Erlanger Health System began a clinical trial to test an artificial intelligence device used to increase polyp detection during colonoscopy, thechattanoogan.com reported Feb. 8.

The GI Quality Improvement Consortium board of directors is going through a leadership transition as Glenn Eisen, MD, steps down after 11 years of service, the American Society for Gastrointestinal Endoscopy announced Feb. 3.

Well Health reached an arrangement agreement to acquire all issued and outstanding shares of CRH Medical at $4 per share, the company announced Feb. 8.

In what's shaping up to be a banner year of private equity investment in gastroenterology, PE Hub reported Feb. 5 that Audax Private Equity will sell Miami-based Gastro Health in 2021.

Gastroenterology's mainstay procedure has seen a flurry of recent developments, and the largest was the closure of the colonoscopy loophole.